SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-072232
Filing Date
2023-06-16
Accepted
2023-06-16 16:08:23
Documents
16
Period of Report
2023-06-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2318809d2_8k.htm   iXBRL 8-K 32982
2 EXHIBIT 1.1 tm2318809d2_ex1-1.htm EX-1.1 241057
3 EXHIBIT 5.1 tm2318809d2_ex5-1.htm EX-5.1 8797
7 GRAPHIC tm2318809d2_ex5-1img001.jpg GRAPHIC 4223
8 GRAPHIC tm2318809d2_ex5-1img002.jpg GRAPHIC 2123
  Complete submission text file 0001104659-23-072232.txt   532289

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA ewtx-20230615.xsd EX-101.SCH 3039
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE ewtx-20230615_lab.xml EX-101.LAB 34476
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ewtx-20230615_pre.xml EX-101.PRE 22599
10 EXTRACTED XBRL INSTANCE DOCUMENT tm2318809d2_8k_htm.xml XML 3601
Mailing Address 1715 38TH ST BOULDER CO 80301
Business Address 1715 38TH ST BOULDER CO 80301 720-262-7002
Edgewise Therapeutics, Inc. (Filer) CIK: 0001710072 (see all company filings)

IRS No.: 821725586 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40236 | Film No.: 231021116
SIC: 2834 Pharmaceutical Preparations